
Relationship of 24-hour ambulatory blood pressure and rennin-angiotensin-aldosterone system in children with primary nephrotic syndrome
XU Zhi-Quan, YI Zhu-Wen, DANG Xi-Qiang, WU Xiao-Chuan, HE Xiao-Jie
Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (10) : 788-792.
Relationship of 24-hour ambulatory blood pressure and rennin-angiotensin-aldosterone system in children with primary nephrotic syndrome
Primary nephrotic syndrome / Ambulatory blood pressure monitoring / Renin-angiotensin-aldosterone system / Child
[1]Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic,clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study[J]. J Paediatr Child Health, 2007, 43(5): 337-341.
[2]Klahr S, Morrissey J, Hruska K, Wang S, Chen Q. New approaches to delay the progression of chronic renal failure[J]. Kidney Int, 2002, 80(Suppl): S23-S25.
[3]Zoccali C,Mallamaci F,Tripepi G.Novel cardiovascular risk factors in end-stage renal disease[J]. J Am Soc Nephrol,2004,15(Suppl 1): S77-80.
[4]Soergel M,Kirschstein M, Busch C, Danne T, Gellermann J, Holl R,et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects[J]. J Pediatr, 1997,130(2): 178-184.
[5]Díaz LN, Garin EH. Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension[J]. Pediatr Nephrol, 2007, 22(4): 554-558.
[6]Ohasi N, Urushihara M, Kobori H. Activated intra renal reactive oxygen species and renin angiotensin system in IgA nephropathy[J]. Minerva Urol Nefrol, 2009, 61(1): 55-66.
[7]Li JS, Baker-Smith CM, Smith PB, Hasselblad V, Murphy MD, Califf RM,et al. Racial difference in blood pressure response to angiotensinconverting enzyme inhibitors in children: a meta-analysis[J]. Clin Pharmacol Ther, 2008, 84(3): 315-319.
[8]中华医学会儿科学分会肾脏病学组. 小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,12(39):746-749.
[9]Jones DP, Richey PA, Alpert BS, Li Rongling. Serum uric acid and ambulatory blood pressure in children with primary hypertension[J]. Pediatr Res, 2008, 64(5): 556-561.
[10]杨霁云. 肾病综合征[M]//胡亚美,江载芳. 诸福棠实用儿科学(下册).第7版.北京:人民卫生出版社,2002: 1641-1648.
[11]李娅,冯晓蓓,章倩莹,任红,张文,陈晓农,等. 慢性肾脏病患者血压昼夜节律异常的研究[J]. 中华肾脏病杂志,2006,22(6):328-331.
[12]Matsuoka S, Awazu M. Masked hypertension in children and young adults[J].Pediatr Nephrol, 2004, 19(6): 651-654.
[13]Pellizzari M, Speiser PW, Carey DE, Fort P, Kreitzer PM, Frank GR. Twenty-four hour ambulatory blood pressure monitoring in adolescents with type 1 diabetes: getting started[J]. J Diabetes Sci Technol, 2008, 2(6): 1087-1093.
[14]Kim YK, Kim HU, Song JY. Ambulatory blood pressure monitoring and blood pressure load in obese children[J]. Korean Circ J, 2009, 39(11): 482-487.
[15]Lubrano R, Travasso E, Raggi C, Guido G, Masciangelo R, Elli M. Blood pressure load, proteinuria and renal function in pre-hypertensive children[J]. Pediatr Nephrol, 2009, 24(4): 823-831.
[16]Krzych LJ, Szydlowski L. Determinants of inappropriate circadian blood pressure variability in children with essential hypertension[J]. Can J Cardiol, 2009, 25(1): 13-16.
[17]欧阳迎春,余琴. “杓型”与“非杓型”高血压病动态血压变异性与早期肾功损害的临床研究[J]. 四川医学,2001,22(8):746-747.
[18]高邮. 原发性高血压动态血压与左室肥厚相关性研究[J].实用医技杂志,2008,15(18):2401-2402.
[19]庄碧珊,侯存月,王硎玫. 原发性高血压患者血压负荷值与无症状性心肌缺血的相关关系的探讨[J]. 中国实用医药,2009, 4(29):1-3.
[20]McKay DW, Myers MG, Bolli P, Chockalingam A. Masked hypertension: a common but insidious presentation of hypertension[J].Can J Cardiol, 2006, 22(7): 617-620.
[21]Pickering TG, Eguchi K, Kario K. Masked hypertension: a review[J]. Hypertens Res, 2007, 30(6): 479-488.
[22]Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review[J]. J Hypertens, 2008, 26(9): 1715-1725.
[23]Leitao CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients[J]. Diabetes Care, 2007, 30 (5): 1255-1260.
[24]Hwang ES, Choi KJ, Kang DH, Nam GB, Jang JS, Jeong YH, et al. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients[J]. Korean J Intern Med, 2007, 22(4): 256-262.
[25]Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage[J]. Pediatr Nephrol, 2005, 20(8): 1151-1155.
[26]Touyz RM. Molecular and cellular mechanisms in vacular injury in hypertension: role of angiotensin II[J]. Curr Opin Nephrol Hypertens, 2005, 14(2): 125-131.
[27]Pavenst-dt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte[J]. Physiol Rev, 2003, 83(1): 253-307.